ADAPTIR-FLEX
Live / Applied — First extension granted (statement of use) (as of 13 Nov 2025)
What this means for you
Not registered yet, but its 09 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98691545
- Mark type
- Stylized text
- Filed
- 09 Aug 2024
- Published for opposition
- 18 Mar 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Therapeutic protein molecules used in the manufacture of pharmaceuticals and biologically-derived medical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, polypeptides, antibodies, and antibody derivatives, for use in the treatment of autoimmune disorders and conditions, and cancer
- Class 040 — Treatment of materials: Production, namely, custom manufacturing for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of cancer and autoimmune disorders and conditions
- Class 042 — Scientific and technological services: Product commercialization in the nature of pharmaceutical product evaluation and product development for third parties of pharmaceuticals and substances, namely, polypeptides, antibodies and antibody derivatives, for use in the treatment of cancer and autoimmune disorders and conditions
Owner
- Aptevo Research and Development LLC, Seattle, WA, US
- Aptevo Research and Development LLC, Seattle, WA, US
Prosecution history
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 1 GRANTED
- 13 Nov 2025 — SOU EXTENSION 1 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2025 — ASSIGNED TO EXAMINER
- 24 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Aug 2024 — NEW APPLICATION ENTERED